NBN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.027790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.948200E-01
Normal-vs-Stage2
1.225600E-01
Normal-vs-Stage3
5.297900E-02
Normal-vs-Stage4
3.445600E-01
Stage1-vs-Stage2
7.421600E-01
Stage1-vs-Stage3
3.644600E-01
Stage1-vs-Stage4
9.976400E-01
Stage2-vs-Stage3
3.228800E-01
Stage2-vs-Stage4
7.879000E-01
Stage3-vs-Stage4
2.551000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.117580E-01
Normal-vs-AfricanAmerican
3.398200E-01
Normal-vs-Asian
1.957770E-02
Caucasian-vs-AfricanAmerican
7.407000E-01
Caucasian-vs-Asian
1.216630E-01
AfricanAmerican-vs-Asian
1.918420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.279980E-01
Normal-vs-Female
8.642000E-02
Male-vs-Female
8.062200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.403840E-01
Normal-vs-Age(41-60Yrs)
1.895760E-01
Normal-vs-Age(61-80Yrs)
7.845900E-02
Normal-vs-Age(81-100Yrs)
2.458600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.184400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.680400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.177400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.173700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.081800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.801000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.657640E-02
Normal-vs-Daily Drinker
2.122600E-01
Normal-vs-Weekly Drinker
9.573900E-02
Normal-vs-Occasional Drinker
1.464620E-01
Normal-vs-Social Drinker
2.156400E-01
Non Drinker-vs-Daily Drinker
7.794600E-01
Non Drinker-vs-Weekly Drinker
7.934200E-01
Non Drinker-vs-Occasional Drinker
2.626400E-01
Non Drinker-vs-Social Drinker
2.327800E-01
Daily Drinker-vs-Weekly Drinker
9.581800E-01
Daily Drinker-vs-Occasional Drinker
6.319600E-01
Daily Drinker-vs-Social Drinker
5.832400E-01
Weekly Drinker-vs-Occasional Drinker
5.419000E-01
Weekly Drinker-vs-Social Drinker
4.962400E-01
Occasional Drinker-vs-Social Drinker
8.885800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.295400E-01
Normal-vs-Grade 2
7.175600E-01
Normal-vs-Grade 3
2.851400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.931700E-02
Grade 1-vs-Grade 3
2.940300E-02
Grade 1-vs-Grade 4
6.295400E-01
Grade 2-vs-Grade 3
1.672830E-01
Grade 2-vs-Grade 4
7.175600E-01
Grade 3-vs-Grade 4
2.851400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.875900E-02
Normal-vs-NonDiabetic
4.335900E-02
Diabetic-vs-NonDiabetic
7.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.797700E-02
Normal-vs-NoPancreatitis
6.911900E-02
Pancreatitis-vs-NoPancreatitis
4.003600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.393600E-02
Normal-vs-N1
1.310020E-01
N0-vs-N1
2.787200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.488800E-01
Normal-vs-TP53-NonMutant
1.127050E-01
TP53-Mutant-vs-TP53-NonMutant
1.625210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
